Koyfin Home > Directory > Health Care > Amphastar Pharma > Cash and Short-Term Investments

Amphastar Pharma Cash and Short-Term Investments Chart (AMPH)

Amphastar Pharma annual/quarterly Cash and Short-Term Investments from 2014 to 2018.
  • Amphastar Pharma Cash and Short-Term Investments for the quarter ending December 12, 2018 was $89m a 35.66% increase of 32m year over year
  • Amphastar Pharma Cash and Short-Term Investments for the last 12 months ending December 12, 2018 was $89m a 35.66% increase of 32m year over year
  • Amphastar Pharma Annual Cash and Short-Term Investments for 2018 was $89m a 22.12% increase of 20m from 2017
  • Amphastar Pharma Annual Cash and Short-Term Investments for 2017 was $69m a -4.95% decrease of -3m from 2016
  • Amphastar Pharma Annual Cash and Short-Term Investments for 2016 was $73m a 9.34% increase of 7m from 2015
Other Balance Sheet Metrics:
  • Amphastar Pharma Total Assets for the quarter ending December 12, 2018 was $514m a 12.42% increase of 64m year over year
  • Amphastar Pharma Other Liabilities for the quarter ending December 12, 2018 was $10m a -0.42% decrease of 0m year over year
  • Amphastar Pharma Total Equity for the quarter ending December 12, 2018 was $364m a 10.22% increase of 37m year over year
View Chart On Koyfin

Quarterly AMPH Cash and Short-Term Investments Data

12/2018$89m
09/2018$72m
06/2018$51m
03/2018$57m
12/2017$68m
09/2017$69m
06/2017$83m
03/2017$78m
12/2016$73m
09/2016$67m

Annual AMPH Cash and Short-Term Investments Data

2018$89m
2017$69m
2016$73m
2015$66m
2014$68m
2013$54m